Mark Holt
About Mark Holt
Mark Holt serves as the Director of Technical Services at Kite Pharma, a position he has held since 2018. He has over 17 years of experience in leadership roles at companies like Amgen and Medtronic, and he holds a Master's degree from California State University, Northridge.
Current Role at Kite Pharma
Mark Holt serves as the Director of Technical Services at Kite Pharma, a position he has held since 2018. In this role, he is responsible for overseeing technical operations and ensuring the successful development and commercialization of innovative therapies. Kite Pharma is known for its focus on cell therapy, particularly in the treatment of cancer. Holt's leadership contributes to the company's mission of advancing transformative therapies for patients.
Previous Experience at Amgen
Mark Holt worked at Amgen for a total of 12 years, holding two significant positions. He served as Director of Device Commercialization from 2006 to 2012, where he focused on the development and launch of medical devices. Following this role, he became the Director of Engineering from 2012 to 2018, overseeing engineering projects and ensuring compliance with industry standards. His extensive experience at Amgen provided him with a strong foundation in the biotechnology sector.
Experience at Medtronic
Prior to his tenure at Amgen, Mark Holt worked at Medtronic as a Product Development Manager from 2001 to 2006. In this role, he was involved in the development of medical devices, contributing to product innovation and improvement. His experience at Medtronic enhanced his skills in product development and project management within the medical technology field.
Educational Background
Mark Holt obtained his Bachelor of Science degree from California State University, Chico, where he studied from 1986 to 1992. He later pursued a Master's degree at California State University, Northridge. His educational background has equipped him with the knowledge and skills necessary for his roles in technical services and product development within the biotechnology and medical device industries.